We examined, in conscious dogs, the potential role of prejunctional a 2 -adrenergic receptors for the regulation of heart rate and contractility response to exercise through modulation of the neurotransmitter release. Changes in heart rate and left ventricular pressure with time during comparable exercise levels, together with changes in norepinephrine concentration in the coronary sinus, were compared before and after the intravenous administration of: prazosin (0.5 mg/kg), a preferential postjunctional a^-adrenergic receptor blocking agent; phentolamine (1 mg/ kg), a nonselective a-adrenergic blocking agent; and yohimbine (0.3 mg/kg), a preferential prejunctional « 2 -adrenergic receptor blocking agent. During exercise after phentolamine or yohimbine, changes in heart rate and left ventricular dP/dt were markedly potentiated compared to the control exercise, as well as to exercise after prazosin, whereas the norepinephrine concentration in the coronary sinus was substantially elevated. After intracoronary administration of phentolamine (0.1 mg/kg) or yohimbine (0.03 mg/kg)/ heart rate and contractility response to exercise were also potentiated, compared to the control exercise. These observations indicate that, in the intact conscious animal, prejunctional a 2 -adrenoreceptors are stimulated during exercise, thereby modulating the norepinephrine release through a negative feedback inhibitory mechanism. Blocking these receptors by phentolamine or yohimbine results in an uncontrolled norepinephrine release dunng exercise associated with an augmented /3-adrenergic receptor-mediated end organ response, i.e., a potentiation in heart rate and contractility response. (Circ Res 54: 683-693, 1984) 
MUSCULAR exercise is associated with an increased sympathetic activation, allowing the heart to augment its performance by increasing force and frequency of contraction. The link between the excitation of the cardiac sympathetic nerves and the chronotropic and inotropic response of the heart occurs through the release of norepinephrine (NE) from the nerve endings which acts on postjunctional 3-adrenergic receptors. In recent years, experimental evidence has accumulated which indicates that this neurotransmitter release is modulated through activation of receptors located in the membrane of the nerve endings, i.e., prejunctional receptors.
Pharmacological studies have revealed the existence of different types of prejunctional receptors, among which prejunctional a 2 -adrenergic receptors have been extensively studied (Langer, 1977 (Langer, , 1980 . Activation of these prejunctional a 2 -receptors was shown to inhibit the NE release during nerve stimulation (Kirpekar et al., 1973; Langer et al., 1977) , while an increase in NE liberation during nerve stimulation was observed in the presence of a 2adrenoreceptor blocking agents Yamaguchi et al., 1977) . The discovery of these prejunctional receptors stimulated the interest in the role of local, release-controlling feedback circuits for regulating the end organ responses. The bulk of evidence supporting the existence of such a negative feedback a-adrenergic mechanism regulating the NE release at the nerve endings, has been accumulated from experiments on isolated perfused organs and anesthetized animal models . The functional role however of this feedback-controlled release of neurotransmitter in the regulation of the effector response of the heart during physiological stress situation has not been elucidated.
Only few studies have tried to correlate the release of NE with the end organ response in isolated organs , as well as in anesthetized animals (Yamaguchi et al., 1975) and conscious animals (Graham and Pettinger, 1979; Graham et al., 1980) . These investigations have led to conflicting results. We have recently found that the heart rate and contractility response to exercise is significantly potentiated after the administration of phentolamine (Heyndrickx et al., 1982) , an observation which could be related to an a-adrenergic mediated altered neurotransmission. The aim of this study was therefore to further analyze this potential functional role of myocardial prejunctional a 2 -adrenergic receptors for the regulation of heart rate and contractility response during exercise, a situation associated with an important activation of the sympathetic nervous system.
In order to analyze this mechanism, we studied the hemodynamic response, together with the changes in NE levels in coronary sinus blood at rest and during exercise, before and after the administration of several a-adrenoreceptor blocking agents with different affinities for «]-and a 2 -adrenergic receptors. If prejunctional a 2 -receptors are indeed activated during exercise, it can be anticipated that, after blocking these receptors either with phentolamine, a nonselective a-blocking agent, or with yohimbine, a selective a 2 -blocker (Starke et al., 1975) , sympathetic stimulation at a given exercise level should result in an increased NE release and, hence, in an augmented heart rate and contractility response as compared to the control exercise run. It can also be anticipated that during exercise in the presence of prazosin, a drug which blocks more specifically the postjunctional ai-adrenoreceptors (Constantine et al., 1973; Cambridge et al., 1977) , such an increased NE release, together with an augmented heart rate and contractility response, will not be observed.
Methods

Chronically Instrumented Animals
Twenty-six dogs of either sex weighing between 23 and 32 kg were anesthetized with sodium pentobarbital, 30 mg/kg, iv, intubated, and artificially ventilated. Surgery was performed by standard sterile techniques. The heart was exposed through a left thoracotomy in the 5th intercostal space. A miniature solid state pressure transducer (Konigsberg Instruments) was implanted through a stab wound in the apex of the left ventricle. After careful dissection of the left circumflex coronary artery, a Doppler ultrasonic flow probe was implanted, 2-3 cm from its origin. At the same time, fluid-filled SUastic (Dow Corning Company) catheters were implanted in the left atrium, descending thoracic aorta, and coronary sinus. All catheters and transducer wires were tunneled subcutaneously to the dorsal neck surface, exteriorized, and fixed to the skin. Postoperatively, all animals were routinely placed on antibiotic therapy for 10 days. A minimum interval of 2 weeks was allowed for recovery from this surgical implantation.
Instrumentation and Experimental Measurements
Left ventricular (LV) systolic and end-diastolic pressures were measured from the implanted solid state pressure transducer, which was calibrated in vitro against a mercury manometer prior to implantation and again at autopsy. Zero adjustment in vivo was performed using the left atrial pressure zero as a reference, after matching the 'a wave" of the left atrial pressure tracing with the a wave of the left ventricular pressure wave form. Continuous records of the rate of changes of LV pressure (P) (i.e., dP/ dt) were derived from the LVP signal with an operational amplifier connected to a differentiator with a resistancecapacitance with 0.05-second time constant and with a Circulation Research/Vo/. 54, No. 6, June 1984 usable frequency response between 0.5 and 700 Hz. A triangle signal with known slope (rate of change) was substituted for the pressure signal to calibrate the dP/dt channel directly. The quotient of LV dP/dt and developed pressure (isovolumic minus end-diastolic pressure), i.e., LV dP/dt/P, was determined at LVP of 40 mm Hg. Continuous records of heart rate were provided by a cardiotachometer triggered by the pressure signal.
Arterial and left atrial pressures were recorded from the implanted fluid-filled catheters connected to a Statham SP 37 strain gauge manometer. To avoid movement artefacts during exercise, the transducer was firmly attached to the chest wall of the dog at mid-chest level. Mean arterial blood pressure was obtained by means of an electronic resistance-capacitance filter with 2-second time constant. Coronary blood flow velocity was measured from the implanted flow probe transducer connected to a nondirectional continuous wave Doppler ultrasonic flow meter described by Franklin et al. (1966) , whereby the ultrasonic transducer is activated by a battery-operated flowmeter unit, and the blood flow signal is telemetered to a standard FM communication receiver. The accuracy and reliability of blood flow measurements obtained by the ultrasonic Doppler flow meter technique have been studied critically, and the linear relationship between blood velocity and volume is well established (Vatner et al., 1970) .
Left circumflex coronary blood flow was computed by multiplying blood flow velocity with the cross-sectional area of the coronary artery. Mean coronary blood flow was obtained by means of an electronic resistance-capacitance filter with a 2-second time constant. Arterial and coronary sinus blood samples were obtained through the implanted catheters. The coronary sinus catheter was constructed and implanted as described by Young and Stone (1974) . Care was taken to have the catheter tip at least 15 mm from the epicardial dimple, marking the point at which the coronary sinus empties into the right atrium. Earlier experiments in our laboratory have shown that no atrial contamination was observed with this technique (Heyndrickx et al., 1980) . Plasma norepinephrine levels were measured using the radioenzymatic COMT-assay of Da Prada and Zurcher (1976) . Duplicate aliquots of each plasma sample were incubated together with duplicate aliquots containing added NE as standards. Blanks consisted of NaIO< oxidized plasma samples. Intra-assay variability assessed by 10 determinations of NE in one plasma sample of the same animal was 11.2%. Interassay variability assessed by 32 determinations of NE of the same plasma sample was 10.5%.
The NE release from the cardiac sympathetic nerves was assessed by calculating the difference between the NE concentration in the coronary sinus and the aorta and expressed as NE gradient across the myocardium.
Experimental Protocol
The experiments were conducted 2-3 weeks after operation when the dogs had fully recovered from surgery and could exercise at the same level as before.
Control values of left ventricular pressure, LV dP/dt, phasic and mean arterial blood pressure, coronary blood flow, and heart rate were recorded while the dogs were standing quietly on the treadmill. The same parameters weTe continuously recorded during exercise, while arterial and coronary sinus blood samples were taken at the 3rd minute of a constant exercise load. The speed and incli-nation of the treadmill during the exercise varied, respectively, between 10 and 15 km/hr and 0 and 5%, and was preselected for each dog so that a submaximal exercise could easily be sustained for at least 5 minutes. Each dog was subjected to one or more control run on different days. Identical runs were performed on separate days after iv administration of an a-adrenergic blocking agent. Fourteen dogs were studied before and after phentolamine (1 mg/kg) and before and after prazosin (0.5 mg/kg), and eight dogs before and after yohimbine (0.3 mg/kg). The effectiveness of the a-adrenergic blockade was tested for phentolamine and prazosin. Phentolamine effectively blocked the pressor response to norepinephrine (1.0 Mg/ kg, iv), and prazosin blocked the pressor response to phenylephrine (5 Mg/kg/ i v )-Yohimbine, in a dose of 0.3 mg/kg, has been shown to block the a 2 -adrenergic receptors adequately (Constantine and Lebel, 1980) . The sequence of the different exercise runs (with or without oreceptor blockade) was chosen at random.
In four dogs, phentolamine and yohimbine were administered intracoronary to eliminate or minimize the systemic effects of the drugs. Phentolamine (0.1 mg/kg) or yohimbine (0.03 mg/kg), diluted in 2 ml saline, was slowly infused intracoronary over 15 minutes through a Judkins left coronary artery catheter after selective catheterization of the left coronary artery. Standard catheterization through the femoral artery was performed under local anesthesia, and fluoroscopy using the Seldinger technique, 15-20 minutes before the exercise run. 685 
Results
Data Analysis
All experiments were conducted on conscious dogs, and data were recorded on a multichannel tape recorder and played back on a multichannel direct writing oscillograph at a paper speed of 100 mm/sec. The data were stored on a HP 1000 computer (Hewlett-Packard) allowing statistical analysis. Mean values and SEM were calculated for all parameters. The data obtained at rest and during exercise before and after the pharmacological interventions were compared with the Wilcoxon's matched pairs signed rank test, using each dog as its own control.
There were no significant differences between the resting control values obtained on different days. All values were obtained during steady state exercise between 2 and 5 minutes after the start of the exercise sequence. A typical response to exercise on phasic wave forms is shown in Figure 1 .
Control Exercise
Hemo'dynamic parameters (n = 14) The hemodynamic changes occurring during control exercise (10-15 km/hr) are summarized in Table  1 . A submaximal exercise run elicited a significant (P < 0.01) increase in heart rate, mean arterial blood pressure, LV systolic and end-diastolic pressure, LV dP/dt, LV dP/dt/P, mean left circumflex coronary blood flow, and a significant (P < 0.01) decrease in late diastolic coronary vascular resistance.
Norepinephrine (n = 8)
Resting NE values in arterial and coronary sinus blood were not significantly different. During exercise, however, NE levels in coronary sinus blood increased 2-fold, which was significantly more than the increase in NE concentration in the arterial blood, resulting in a positive gradient across the myocardium indicating net production of NE (Table 2).
ai-Adxenergic Receptor Blockade with Prazosin
Hemodynamic Parameters at Rest (n = 14) Prazosin, 0.5 mg/kg, iv, resulted in a slight but significant (P < 0.01) decrease in mean arterial blood pressure, LV end-diastolic pressure, and late diastolic coronary vascular resistance. Heart rate was FIGURE 1. Effects of exercising in a conscious dog on phasic and mean left circumflex coronary blood flow, left ventricular pressure (LVP), LV dP/dt, heart rate, and mean arterial blood pressure in control conditions and in the presence of phentolamine 0 mg/kg, iv) and prazosin (0.5 mg/ kg, iv). Exercising in the presence of phentolamine was associated with a significant potentiation of the inotropic and chronotropic response. Values are means ± SEM.
• SIGNIFICANTLY DIFFERENT FROM RESTING VALUE, P < 0.01. t Significantly different from resting value, P < 0.02. X Significantly different from resting value, P < 0.05 § Significantly different from control exercise, P < 0.01. | Significantly different from control exercise, P < 0 02. H Significantly different from control exercise, P < 0.05. significantly (P < 0.01) increased but not LV dP/dt nor LV dP/dt/P. Resting coronary blood flow increased slightly but not significantly after prazosin (Table 1) .
Norepinephrine Levels at Rest (n = 8)
Resting levels of NE in coronary sinus and arterial blood were not significantly different after the administration of prazosin (Table 2) .
Hemodynamic Parameters during Exercise (n = 14)
During exercise after prazosin, the increases in heart rate, mean coronary blood flow, late diastolic coronary vascular resistance, LV dP/dt, and LV dP/ dt/P were not significantly different from the changes observed during control exercise. However, mean arterial pressure, LVP, and LV end-diastolic pressure increased significantly less (P< 0.01) (Table  1 ; Fig. 1 ).
Norepinephrine Levels during Exercise (n = 8)
The increase in NE levels in the coronary sinus blood as well as in the arterial blood were slightly but significantly (P < 0.01) greater than during control exercise. However, the NE levels increased proportionally in the coronary sinus and arterial blood so that the NE gradient during exercise did not differ significantly from control exercise (Table  2) .
cti-and a 2 -Adrenergic Receptor Blockade with Phentolamine
Hemodynamic Parameters at Rest (n = 14) Phentolamine, 1 mg/kg, iv, resulted in a slight but significant (P < 0.01) decrease in mean arterial blood pressure, LV systolic and end-diastolic pressure, and late diastolic coronary vascular resistance. After phentolamine heart rate, LV dP/dt and LV dP/dt/P were significantly (P < 0.01) increased and so was mean coronary blood flow (Table 1) .
Norepinephrine Levels at Rest (n = 8) After the administration of phentolamine, NE concentration increased both in the coronary sinus blood and in the arterial blood. The NE gradient across the myocardium increased but did not reach significancy (Table 2) .
Hemodynamic Parameters during Exercise (n = 14)
During exercise after phentolamine heart rate, LV dP/dt and LV dP/dt/P increased significantly more, compared to either the control run (P < 0.01) or the exercise after prazosin (P < 0.01). Concurrently, mean coronary blood flow rose more, also, compared to control exercise (Table 1) ( Fig. 1) .
Norepinephrine Levels during Exercise (n = 8)
During exercise after phentolamine, NE concentration increased significantly further in the coronary sinus blood and to a lesser degree in the arterial blood, resulting in a positive NE gradient across the myocardium. This NE gradient during exercise was significantly greater than during control exercise (P < 0.01) or exercise after prazosin (P < 0.01) (Table 2).
a 2 -Adrenergic Receptor Blockade with Yohimbine
Hemodynamic Parameters at Rest (n = 8) After the administration of yohimbine, 0.3 mg/ kg, iv, there was a marked rise in mean arterial blood pressure (P < 0.01). Heart rate, mean coronary blood flow, LV dP/dt, and LV dP/dt/P were also significantly elevated (P < 0.01), while late coronary vascular resistance did not change (Table 1) .
Norepinephrine Levels at Rest (n = 4)
Resting values for NE in coronary sinus blood and arterial blood increased significantly (P < 0.05). The NE gradient across the myocardium was slightly but significantly (P < 0.05) augmented, indicating also a net release of NE (Table 2) .
Hemodynamic Parameters during Exercise (n = 8)
A typical response on phasic waveforms to exercise after yohimbine administration is shown in Figure 2 . During exercise changes in heart rate, LV dP/dt, LV dP/dt/P, and mean coronary blood flow were comparable to the data observed during exercise after phentolamine, i.e., all these parameters increased significantly more than during control exercise. Late diastolic coronary vascular resistance decreased significantly less during exercise in the presence of yohimbine (Table 1) .
Norepinephrine Levels during Exercise (n = 4)
During exercise in the presence of yohimbine, NE concentration increased significantly further in the coronary sinus blood and, to a lesser degree, in the arterial blood. The positive NE gradient across the myocardium, already present after yohimbine at rest, increased significantly more during exercise compared to control exercise (P < 0.05) ( Table 2) .
Intracoronary Administration of Phentolamine
Hemodynamic Parameters at Rest (n = 4) After intracoronary administration of phentolamine (0.1 mg/kg) in supine position, mean arterial pressure did not change but heart rate and LV dP/ dt increased slightly.
Norepinephrine Levels at Rest (n = 3)
Resting values for NE in coronary sinus blood were approximately 100% higher after intracoronary administration of phentolamine.
Hemodynamic Parameters during Exercise (n = 4)
During exercise, changes in hemodynamic variables were comparable to the changes observed during exercise after intravenous phentolamine, i.e., changes in heart rate and LV dP/dt were greater than during control exercise (Table 3) .
Norepinephrine Levels during Exercise (n = 3)
After intracoronary phentolamine, NE in coronary sinus as well as NE gradient across the myocardium increased more during exercise, compared to control exercise (Table 3) 
FIGURE 2. Effects of exercising m a conscious dog on phasic and mean left circumflex coronary blood flow, left ventricular pressure (LVP), LV dP/dt, heart rate, and mean arterial blood pressure in control conditions and in the presence of yohimbine. Exercising in the presence of yohimbine was associated with a significantly larger increase in LV dP/dt and heart rate.
Intracoronary Administration of Yohimbine
Hemodynamic Parameters at Rest (n = 4) After intracoronary administration of yohimbine (0.03 mg/kg), mean arterial pressure, heart rate, and LV dP/dt increased slightly.
Norepinephrine Levels at Rest (n = 3)
After intracoronary administration of yohimbine, baseline values of NE in coronary sinus and arterial blood increased.
Hemodynamic Parameters during Exercise (n = 4)
During exercise, changes in heart rate and LV dP/ dt were quantitatively similar as observed during exercise after iv yohimbine, i.e., heart rate and LV dP/dt increased more than during control exercise.
Norepinephrine Levels during Exercise (n = 3,) During exercise after intracoronary yohimbine, changes in coronary sinus norepinephrine levels were quantitatively similar to the changes obtained during exercise after iv yohimbine. The NE gradient across the myocardium was greater compared to the control exercise (Table 3 ).
Discussion
The aim of the present study was to test the hypothesis that norepinephrine release from myocardial sympathetic nerve endings during exercise may be modulated through prejunctional a 2 -adrenoreceptors and, hence, may regulate the chronotropic and inotropic responses in the intact conscious animal. The evidence for an autoinhibitory system in the regulation of NE release, mediated through prejunctional a 2 -adrenoreceptors, has been obtained in studies in vitro , as well as in vivo (Cavero et al., 1979) . Prejunctional a 2 -adrenoreceptors, located in the neuronal membrane, are stimulated whenever the concentration of the neurotransmitter in the synaptic gap reaches a threshold level resulting in an attenuation of further NE release. Blocking these prejuncrional a 2 -receptors results in an increased NE release during sym- In the presence of phentolamine and yohimbine, exercise produced a significantly greater increase in heart rate. Mean arterial blood pressure increased significantly less with phentolamine and prazosin but increased more in the presence of yohimbine. Mean coronary blood flow increased more in the presence of phentolamine and yohimbine pathetic stimulation and has been well documented in experiments using a technique of loading noradrenergic neurones with [ 3 H]norepinephrine (Mc-Culloch et al., 1972; Langer et al., 1977) . Yamaguchi et al. (1977) have also shown in anesthetized dogs that NE release during stimulation of the cardiac nerves is augmented after a 2 -receptor blockade. However, in their experiments, the marked increase in NE release was not associated with a significant potentiation of heart rate and contractility response during cardiac nerve stimulation. This would indicate that, although a negative feedback mechanism can be demonstrated pharmacologically, its impact on the effector organ is negligible in anesthetized animals. Kalsner (1980) , as well as Angus and Korner (1980) , have in fact challenged the view that the changes in transmitter output observed with different a-receptor agonists and antagonists, are caused by an interference with a functional auto-inhibitory system mediated by prejunctional a-adrenoreceptors. A number of observations in conscious animals and humans, however, suggest that interfering with the auto-inhibition of neurotransmitter release does Circulation Research/Vo /. 54, No. 6, June 1984 affect the effector organ response (Graham and Pettinger, 1979; Graham et al., 1980) .
In a recent study, Saeed et al. (1982) provided additional evidence for a functional role of prejunctional a 2 -receptors in resting conscious dogs, when they observed that the systemic hypotensive effect of phentolamine was associated with increased levels of plasma NE. Pretreatment with propranolol abolished the hypotensive effect of phentolamine but not the increments in plasma NE levels. These authors concluded that the observed vasodilation after phentolamine was not due to withdrawal of aadrenergic tone secondary to postsynaptic <*i -receptor blockade but, rather, a consequence of /3 2 -receptor stimulation initiated by an increased NE release, secondary to prejunctional a 2 -receptor blockade of phentolamine.
This raised the question as to whether modulation of neurotransmitter release could also be demonstrated during physiological stress situations, such as exercise in the intact conscious animal. If prejunctional a 2 -adrenergic receptors are indeed activated, exercising after blocking these prejunctional receptors will be associated with an increased NE release at the nerve endings. Consequently, it can be anticipated that an increased neurotransmitter concentration at the synaptic cleft will enhance the target organ response of the myocardium through /S-adrenergic receptor stimulation and result in an augmented chronotropic and inotropic response.
In an attempt to elucidate the possible functional role of prejunctional a 2 -adrenergic receptors in a physiological stress situation, we have correlated the changes occurring in NE concentration in coronary sinus blood with changes in heart rate and LV dP/dt during exercise before and after the administration of different a-adrenergic receptor blocking agents. Indeed, Yamaguchi et al. (1975) and Cavero et al. (1979) have shown that changes in NE release during cardiac sympathetic nerve stimulation are closely reflected in the changes occurring in the catecholamine levels in coronary sinus blood.
The data presented in this study clearly show that heart rate and contractility responses during submaximal exercise after pretreatment with phentolamine were significantly greater than the responses obtained during either control exercise or exercise after prazosin ( Figs. 3 and 4) . Concurrently, the NE overflow measured in the coronary sinus blood during exercise after phentolamine was also increased, compared to both the exercise in control conditions and after prazosin (Fig. 5 ). Since prazosin and phentolamine have different affinities for ct\-and a 2adrenergic receptors, with prazosin blocking more selectively «i receptors and phentolamine blocking equally well a\-and a 2 -receptors, the differences observed during exercise may be related to the attenuation of the prejunctional a 2 inhibitory effect of NE release at the nerve endings. Indeed, after phentolamine, NE concentration in the coronary sinus blood, already increased at rest, augmented significantly more during exercise as compared to the exercise after prazosin. A direct inhibitory effect of phentolamine on the neuronal uptake of norepinephrine could also alter the neurotransmitter concentration at the synaptic cleft and so explain our results. However, this is unlikely, since phentolamine only blocks the NE uptake process at much higher doses than used in this study (Iversen, 1973) . It is important to note that the augmentation of the NE concentration in the coronary sinus during exercise after phentolamine occurred in the presence of larger increase in coronary blood flow as compared to the control exercise which, in the presence of an unchanged release, would tend to decrease the NE concentration. Therefore, the NE concentration measured in the coronary sinus blood during exercise underestimates the total amount of NE released. Additional support for a prejunctional ct 2effect of phentolamine was found in the quantitatively similar results obtained during exercise after administration of yohimbine, a drug known to block selectively the prejunctional a 2 -receptors (Starke et al., 1975) .
In formulating this conclusion, one important assumption was made, namely, that sympathetic nerve traffic to the heart during exercise would be similar during all exercise sequences. Since the degree of sympathetic outflow to the heart will be proportional to the work load, a standardized protocol was preferred over free-ranging exercise, so that the external exercise load would be identical during all different runs. Other factors besides the exercise level may, however, also affect the nerve traffic to the heart and, hence, at least partially be responsible for the observed results.
Reflex Activation of the Central Sympathetic System
It is well known that activation of the sympathetic nerves during exercise is triggered by a number of afferent impulses originating from peripheral receptors such as the carotissinus and the aortic baroreceptors, as well as low pressure receptors in the heart and the lungs. Thus, it could be argued that the lower mean arterial blood pressure, as well as end-diastolic pressure which is observed after phentolamine, would change the extent of stimulation of these receptors and elicit reflexly a different degree of sympathetic drive to the heart during exercise, despite the fact that the external exercise-load is kept constant.
As a result of the decrease in afferent baroreceptor impulses, the sympathetic output to the myocardium will increase, thereby augmenting heart rate and contractility. Such a reflex positive chronotropic and inotropic effect after phentolamine has been illustrated by several investigators. (Singh et al., 1970; Bagwell et al., 1980) . However, that the changes observed in chronotropic and inotropic activity of the heart, as well as in the NE output in the coronary sinus blood after phentolamine, cannot be explained exclusively by the lower blood pressure is indicated by the observations made during exercise after prazosin.
Despite a similar arterial blood pressure drop pro- duced by phentolamine and prazosin, different effects on heart rate and contractility and on NE output were observed. Phentolamine (1 mg/kg, iv) increased heart rate, LV dP/dt, and NE concentrations in coronary venous blood to a much greater extent (P < 0.01) than did prazosin (0.5 mg/kg, iv). An explanation which can be offered for these differences is that phentolamine, apart from the expected rise in sympathetic tone in response to a hypotensive baroreceptor reflex, exerts also more specific effects which are not shared by prazosin. Differences in blocking properties of phentolamine and prazosin towards a^-and «2-adrenergic receptors offer a logical explanation for these observations. Such a viewpoint is strengthened by the observations made during exercise experiments after yohimbine, a substance accepted to block preferentially a 2 -receptors. Yohimbine (0.3 mg/kg, iv) also yielded a quantitatively similar increase in heart rate and contractility, as did phentolamine, despite the larger rise in mean arterial blood pressure, which, through vagal stimulation, will tend to attenuate the sympathetic outflow to the heart, thereby blunting the heart rate and LV dP/dt increases. These hemodynamic effects of yohimbine were also associated with an increased neurotransmitter overflow in the coronary sinus. This corroborates the results of Graham et al. (1980) who demonstrated a marked and sustained increase in plasma norepinephrine levels associated with an increased heart rate in conscious rats after phentolamine and yohimbine.
Direct Activation of the Central Sympathetic System
The administration of a-receptor blocking agents intravenously will not only affect the myocardial receptors, but also receptors in other peripheral vascular beds as well. Indeed, McCall et al. (1983) have shown that phentolamine and yohimbine can readily cross the blood-brain barrier, resulting in centrally mediated increase in sympathetic outflow to the heart, while prazosin may reduce sympathetic nerve discharge through central ai-adrenergic blockade (McCall and Humphrey, 1981) . This possibility must also be considered in our experiments. Unless nerve traffic to the heart is directly measured, no definite statement concerning a possible central effect can be made.
Some indirect evidence that the increased NE overflow during exercise after phentolamine or yohimbine was not merely mediated through central effects of the drugs is given by the results of the exercise experiments after intracoronary administration of phentolamine and yohimbine.
The administration of phentolamine and yohimbine (l/10th of the intravenous dose) directly into the coronary artery which would tend to minimize the amount of the drug reaching the brain, thereby confining the effect of a-adrenergic receptor blockade to the myocardium yielded qualitatively comparable results as observed after the intravenous administration of the drugs.
After intracoronary administration of both phentolamine and yohimbine, the increase in heart rate and LV dP/dt during exercise was greater than during control exercise. This potentiation of heart rate and contractility response to exercise was also accompanied by an augmented release of NE in the coronary sinus blood, strongly suggesting that the increased release of NE during exercise was a consequence of blocking prejunctional a2-receptors at the myocardial level rather than the result of a centrally mediated effect of the antagonist. However, some central effect due to appearance of the antagonist in the systemic circulation cannot completely be ruled out as indicated by a small increase in arterial NE levels seen after intracoronary administration of yohimbine.
The small number of animals studied with intracoronary administration of the antagonists may explain why the changes in LV dP/dt during exercise after both phentolamine and yohimbine do not exactly parallel the changes in NE gradient, as was observed with intravenous administration of the drugs.
In conclusion, the results of the present investigation indicate that, in conscious animals, the release of NE at the adrenergic nerve endings during sympathetic stimulation is modulated by a negative feedback mechanism regulated by prejunctional a 2adrenergic receptors. Interfering with this regulatory mechanism by phentolamine or yohimbine results in an increased NE release in the myocardium which potentiates the (S-adrenergic-mediated response of the heart during exercise. This modulating effect tends to optimize the release of neurotransmitter in response to sympathetic stimulation during exercise so as to avoid an uncontrolled increase in heart rate and contractility thereby limiting the myocardial oxygen consumption.
